The novel therapy of the medication represents a exciting advance in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide617402.designi1.com/62728029/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment